| Autor: |
A.M. Othman, M.A. Motaleb, I.T. Ibrahim, M. E. Moustafa |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Benha Journal of Applied Sciences. 6:231-236 |
| ISSN: |
2356-976X |
| DOI: |
10.21608/bjas.2021.169114 |
| Popis: |
This study aimed to prepare a novel radiopharmaceutical for the detection of brain disorders at early stages in susceptible patients.Promazine hydrochloride was labeled with 125I by direct electrophilic substitution reaction with high labeling yields of 92.6 ± 3.24 %. The labeling yield and in vitro stability of 125I-promazine were determined by paper electrophoresis, paper chromatography (PC) and High performance liquid chromatography (HPLC). In vitro studies showed that the highest radiochemical yield of 125I-promazine (92.6±3.24%) was stable up to 6 h. Biodistribution studies showed that maximum uptakes of 125I-promazine in the brain of mice was 5.4 ± 0.18 % injected dose/g after 30 min post-injectionwhich is higher than that of 99mTc-HMPAO and 99mTc-ECD (2.25 and 4.7 %, respectively), so this confirms the high specificity and selectivity of this radiotracer for brain and could be used for brain imaging instead of the commercially available 99mTc-HMPAOand 99mTc-ECD. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
